Advertisement

Immune-mediated diseases in primary sclerosing cholangitis

      Abstract

      Background

      Primary sclerosing cholangitis is a chronic cholestatic liver disease. An immune aetiology is suggested by associations between PSC and inflammatory bowel disease. Data on concomitant prevalence of other immune-mediated diseases is limited.

      Aim

      To assess the prevalence of concomitant immune-mediated diseases and the impact on disease outcome in PSC.

      Methods

      We included 241 patients and retrospectively reviewed medical charts.

      Results

      Altogether 172 (71.4%) patients had concomitant immune-mediated disease, including IBD (149, 61.8%), autoimmune hepatitis (15, 6.2%) and other immune-mediated diseases (47, 19.5%). Thirty nine patients (22.7%) had more than one immune-mediated disease other than PSC. Most frequent extrahepatic non-IBD immune-mediated diseases were sarcoidosis, thyroid disease, and type I diabetes mellitus.
      Age at PSC diagnosis was lower in patients with IBD. In patients with other immune-mediated diseases than autoimmune hepatitis or IBD, age at PSC diagnosis was higher. Younger age at diagnosis and concomitant IBD related to longer survival till death or liver transplantation.

      Conclusions

      In a large PSC population, a high prevalence of concomitant immune-mediated diseases was found. IBD occurred more often in early-acquired PSC, and the other immune-mediated diseases more often in later-acquired PSC. No effect on outcome was found for non-IBD immune mediated disease.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bambha K.
        • Kim W.R.
        • Talwalkar J.
        • et al.
        Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community.
        Gastroenterology. 2003; 125: 1364-1369
        • Boberg K.M.
        • Aadland E.
        • Jahnsen J.
        • et al.
        Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.
        Scand. J. Gastroenterol. 1998; 33: 99-103
        • Broome U.
        • Olsson R.
        • Loof L.
        • et al.
        Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
        Gut. 1996; 38: 610-615
        • Farrant J.M.
        • Hayllar K.M.
        • Wilkinson M.L.
        • et al.
        Natural history and prognostic variables in primary sclerosing cholangitis.
        Gastroenterology. 1991; 100: 1710-1717
        • Tischendorf J.J.
        • Hecker H.
        • Kruger M.
        • et al.
        Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study.
        Am. J. Gastroenterol. 2007; 102: 107-114
        • Talwalkar J.A.
        • Lindor K.D.
        Primary sclerosing cholangitis.
        Inflamm. Bowel Dis. 2005; 11: 62-72
        • Angulo P.
        • Peter J.B.
        • Gershwin M.E.
        • et al.
        Serum autoantibodies in patients with primary sclerosing cholangitis.
        J. Hepatol. 2000; 32: 182-187
        • Bodenheimer Jr., H.C.
        • LaRusso N.F.
        • Thayer Jr., W.R.
        • et al.
        Elevated circulating immune complexes in primary sclerosing cholangitis.
        Hepatology. 1983; 3: 150-154
        • Boberg K.M.
        • Fausa O.
        • Haaland T.
        • et al.
        Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis.
        Hepatology. 1996; 23: 1369-1376
        • Ponsioen C.Y.
        • Kuiper H.
        • Ten Kate F.J.
        • et al.
        Immunohistochemical analysis of inflammation in primary sclerosing cholangitis.
        Eur. J. Gastroenterol. Hepatol. 1999; 11: 769-774
        • Schrumpf E.
        • Fausa O.
        • Forre O.
        • et al.
        HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease.
        Scand. J. Gastroenterol. 1982; 17: 187-191
        • Karlsen T.H.
        • Franke A.
        • Melum E.
        • et al.
        Genome-wide association analysis in primary sclerosing cholangitis.
        Gastroenterology. 2010; 138: 1102-1111
        • Bergquist A.
        • Lindberg G.
        • Saarinen S.
        • Broome U.
        Increased prevalence of primary sclerosing cholangitis among first-degree relatives.
        J. Hepatol. 2005; 42: 252-256
        • Schrumpf E.
        • Elgjo K.
        • Fausa O.
        • et al.
        Sclerosing cholangitis in ulcerative colitis.
        Scand. J. Gastroenterol. 1980; 15: 689-697
        • Olsson R.
        • Danielsson A.
        • Jarnerot G.
        • et al.
        Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis.
        Gastroenterology. 1991; 100: 1319-1323
        • Aadland E.
        • Schrumpf E.
        • Fausa O.
        • et al.
        Primary sclerosing cholangitis: a long-term follow-up study.
        Scand. J. Gastroenterol. 1987; 22: 655-664
        • Loftus Jr., E.V.
        • Harewood G.C.
        • Loftus C.G.
        • et al.
        PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.
        Gut. 2005; 54: 91-96
        • Beuers U.
        • Rust C.
        Overlap syndromes.
        Semin. Liver Dis. 2005; 25: 311-320
        • Rust C.
        • Beuers U.
        Overlap syndromes among autoimmune liver diseases.
        World J. Gastroenterol. 2008; 14: 3368-3373
        • van Buuren H.R.
        • van Hoogstraten H.J.E.
        • Terkivatan T.
        • et al.
        High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis.
        J. Hepatol. 2000; 33: 543-548
        • Saarinen S.
        • Olerup O.
        • Broome U.
        Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis.
        Am. J. Gastroenterol. 2000; 95: 3195-3199
        • Chapman R.W.
        • Arborgh B.A.
        • Rhodes J.M.
        • et al.
        Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology.
        Gut. 1980; 21: 870-877
        • Evans J.G.
        • Acheson E.D.
        An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area.
        Gut. 1965; 6: 311-324
        • Farmer R.G.
        • Hawk W.A.
        • Turnbull Jr., R.B.
        Clinical patterns in Crohn's disease: a statistical study of 615 cases.
        Gastroenterology. 1975; 68: 627-635
        • Hennes E.M.
        • Zeniya M.
        • Czaja A.J.
        • et al.
        Simplified criteria for the diagnosis of autoimmune hepatitis.
        Hepatology. 2008; 48: 169-176
        • Van Steenbergen W.
        • Fevery J.
        • Vandenbrande P.
        • et al.
        Ulcerative colitis, primary sclerosing cholangitis, bile duct carcinoma, and generalized sarcoidosis, Report of a unique association.
        J. Clin. Gastroenterol. 1987; 9: 574-579
        • Ilan Y.
        • Rappaport I.
        • Feigin R.
        • Ben-Chetrit E.
        Primary sclerosing cholangitis in sarcoidosis.
        J. Clin. Gastroenterol. 1993; 16: 326-328
        • Alam I.
        • Levenson S.D.
        • Ferrell L.D.
        • Bass N.M.
        Diffuse intrahepatic biliary strictures in sarcoidosis resembling sclerosing cholangitis. Case report and review of the literature.
        Dig. Dis. Sci. 1997; 42: 1295-1301
        • Tombazzi C.
        • Waters B.
        • Ismail M.K.
        • et al.
        Sarcoidosis mimicking primary sclerosing cholangitis requiring liver transplantation.
        Ann. Hepatol. 2008; 7: 83-86
        • Okolicsanyi L.
        • Fabris L.
        • Viaggi S.
        • et al.
        Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group.
        Eur. J. Gastroenterol. Hepatol. 1996; 8: 685-691
        • Somers E.C.
        • Thomas S.L.
        • Smeeth L.
        • Hall A.J.
        Autoimmune diseases co-occurring within individuals and within families: a systematic review.
        Epidemiology. 2006; 17: 202-217
        • Fasano A.
        Systemic autoimmune disorders in celiac disease.
        Curr. Opin. Gastroenterol. 2006; 22: 674-679
        • Teufel A.
        • Weinmann A.
        • Kahaly G.J.
        • et al.
        Concurrent autoimmune diseases in patients with autoimmune hepatitis.
        J. Clin. Gastroenterol. 2010; 44: 208-213
        • Zhernakova A.
        • van Diemen C.C.
        • Wijmenga C.
        Detecting shared pathogenesis from the shared genetics of immune-related diseases.
        Nat. Rev. Genet. 2009; 10: 43-55
        • Cullen S.N.
        • Chapman R.W.
        Review article: current management of primary sclerosing cholangitis.
        Aliment. Pharmacol. Ther. 2005; 21: 933-948
        • Hommes D.W.
        • Erkelens W.
        • Ponsioen C.
        • et al.
        A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis.
        J. Clin. Gastroenterol. 2008; 42: 522-526